Intra‐CSF topotecan in treatment of breast cancer patients with leptomeningeal metastases

Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy

(2019) Nicholas B. Figura et al.   BREAST CANCER RESEARCH AND TREATMENT

Intrathecal trastuzumab in the management of HER2+ breast leptomeningeal disease: a single institution experience

(2018) Nicholas B. Figura et al.   BREAST CANCER RESEARCH AND TREATMENT

Clinicopathological and Treatment‐Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology

(2018) Gaia Griguolo et al.   ONCOLOGIST

A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis

(2015) Pei-Fang Wu et al.   BMC CANCER

Breast Cancer Leptomeningeal Metastasis: The Results of Combined Treatment and the Comparison of Methotrexate and Liposomal Cytarabine As Intra–Cerebrospinal Fluid Chemotherapy

(2015) Anna Niwińska et al.   Clinical Breast Cancer

Intravenous thiotepa for treatment of breast cancer-related leptomeningeal carcinomatosis: case series

(2015) Jaspreet Chahal et al.   NEUROLOGICAL SCIENCES

Leptomeningeal metastasis in breast cancer – a systematic review

(2015) Brian J. Scott et al.   Oncotarget

Leptomeningeal disease and breast cancer: the importance of tumor subtype

(2014) Sausan Abouharb et al.   BREAST CANCER RESEARCH AND TREATMENT

Salvage intracerebrospinal fluid thiotepa in breast cancer-related leptomeningeal metastases

(2013) Emilie Le Rhun et al.   ANTI-CANCER DRUGS

Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis

(2013) Flora Zagouri et al.   BREAST CANCER RESEARCH AND TREATMENT

Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience

(2013) Jae-Cheol Jo et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Breast cancer and leptomeningeal disease (LMD): hormone receptor status influences time to development of LMD and survival from LMD diagnosis

(2013) S. Yust-Katz et al.   JOURNAL OF NEURO-ONCOLOGY

A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer

(2013) E. Le Rhun et al.   JOURNAL OF NEURO-ONCOLOGY

Phase II clinical trial of whole-brain irradiation plus three-dimensional conformal boost with concurrent topotecan for brain metastases from lung cancer

(2013) Xiao-hui Ge et al.   Radiation Oncology

Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases

(2011) Nancy U. Lin et al.   JOURNAL OF NEURO-ONCOLOGY

Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: A Children's Oncology Group trial (P9962)

(2011) Samara L. Poplack Potter et al.   PEDIATRIC BLOOD & CANCER

Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors

(2010) Robert J. Morgan et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies

(2008) Morris D. Groves et al.   NEURO-ONCOLOGY